ADR Monitoring Practices in Pharmacovigilance

Abstract

Pharmacovigilance (PV or PhV) is known as drug safety and is all about identifying, detecting, assessing, monitoring, and avoiding drug side effects. Pharmacovigilance is focused on identifying potential risks connected with pharmaceutical products and decreasing the risk of patient harm. The present review has been done to understand the advances in the pharmacovigilance programme globally and to be aware of the limitations in this area in India so that efforts can be made to overcome them and ensure greater levels of patient safety. Although India has a formal system for reporting, recording, and analyzing adverse drug responses in order to assist regulators in making future decisions about the use of dubious pharmaceuticals, the country currently lacks a reliable and complete pharmacovigilance system. To address this shortage, all stakeholders including clinical pharmacists, healthcare administrators, drug regulatory authorities, pharmaceutical companies, healthcare professionals, academic institutions, government, media representatives, health insurance companies, and patients must work together in coordination and collaboration. Only a concerted and honest effort in this area will ensure that India achieves the highest degree of patient safety.